FSLR heads into the final week of August with shorts covering at pace, analysts lifting targets, and the stock sitting nearly 30% below where the Street thinks it should trade.
The most striking move this week is the sharp pullback in short positioning. Short interest dropped roughly 8% in a single session on August 25, bringing it down to 9.1% of the free float — still a meaningful level, but the direction is clearly toward covering rather than accumulation. The one-month picture tells the fuller story: shorts built positions aggressively through early August, pushing SI from around 8.2% to a peak near 10.7%, before reversing course. Borrow conditions confirm this is a well-supplied trade with no squeeze dynamics. Availability is running at roughly 768% of the outstanding short interest — well above normal — and cost to borrow is near-negligible at 0.44%, up only modestly on the week. The lending market offers no friction to either side.
Options positioning has tilted more defensive than it was a month ago. The put/call ratio has climbed to 0.66 and is running close to 1.8 standard deviations above its 20-day average of 0.60. That's not extreme — the 52-week high is 1.02 — but the drift higher over the past fortnight is noticeable, coinciding with the stock's 6% weekly decline and the retreat from $249 intraday highs seen earlier in August. Together, the short covering and the options caution paint a picture of positioning that is net lighter on the bearish side, but with hedges being quietly layered back in.
The Street is more constructive than the stock's current price implies. Deutsche Bank raised its target to $299 today, and Morgan Stanley pushed its target to $323 last week — the biggest single move in the peer group recently. Wells Fargo and Citigroup have also lifted targets in the past month, while Evercore made only a token trim to $218. The consensus sits at Hold with nine holds on record, but the direction of travel among the active target-raisers is emphatically bullish. The mean target across recent movers implies upside of roughly 35-40% from current levels at $206.82. The valuation offers some support for that argument: the stock trades on a trailing P/E around 10.7x and EV/EBITDA of 7.3x — modest multiples for a company the bull case describes as the world's dominant thin-film solar manufacturer. The bear case is pointed: around a third of investors reportedly expect guidance cuts, quality issues linger, and backlog coverage through 2026 is thinning. That tension is reflected in the ORTEX factor scores — analyst recommendation divergence ranks in the 95th percentile universe-wide, meaning the gap between the most bullish and most bearish views on FSLR is unusually wide.
One institutional flow worth noting: Capital Research and Management added over 3.7 million shares in the most recent reporting period — a position increase of extraordinary scale relative to other holders — bringing its stake to 3.83% of shares outstanding. That's a significant commitment from a major active manager and represents the largest single incremental buy among the top 15 holders.
Insider activity points the other way, though at subdued scale. The General Counsel sold $923k worth of stock on August 11, and the CTO sold across multiple transactions in early August at prices between $218 and $249. These are the sort of plan-driven sales typical of executives managing compensation awards rather than a coordinated exit — none broke $1 million individually — but the net insider flow over 90 days is mildly negative. The next earnings print is scheduled for October 27, and what the Street is likely to focus on between now and then is whether the company can defend its guidance range and whether CdTe spot price trends continue improving — the variable the bulls are hanging their targets on.
See the live data behind this article on ORTEX.
Open FSLR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
